The fear of progression of Parkinson’s Disease
Objective: Determine fear of progression (FoP) and its influencing factors in Parkinson's disease (PD) patients to alleviate the psychosocial distress it induces. Background: PD patients…The effect of Tuina in Traditional Chinese Medicine in treatment of Parkinson’s disease (Non-motor symptoms): a pilot clinical study
Objective: To evaluate the efficacy and safety of Tuina treatment in treating non-motor symptoms (NMS) of Parkinson’s disease (PD) and provide preliminary data for conducting…Night Vision Blindness Should Be Discussed with our Parkinson’s Disease Patients – sooner rather than later.
Objective: Visual disturbances are a common non-motor symptom of Parkinson's Disease (PD) though this is not often intuitive to many providers caring for PD patients. …Validation of the UCLA Loneliness Scale in Parkinson’s Disease During a Period of Social Distancing
Objective: To examine the association between UCLA loneliness questionnaire (ULQ) scores and motor and non-motor symptoms (NMS) and Quality of Life (QoL) in Parkinson Disease…Efficacy of a 6-week brisk walking program in improving non-motor symptoms in people with Parkinson disease – a randomized controlled trial
Objective: To examine whether the brisk walking program would be effective in alleviating non-motor symptoms, and improving sleep quality and health-related quality-of-life (HRQoL) in people…Nonmotor effects of subthalamic stimulation in Parkinson’s disease motor subtypes
Objective: To compare bilateral subthalamic stimulation (STN-DBS) effects on quality of life (QoL), motor, and nonmotor symptoms (NMS) in ‘tremor-dominant’ and ‘postural instability and gait…Strategies for Social Prescribing: Combating Loneliness in Parkinson’s Disease
Objective: To examine the association between online social engagement (SE) including exercise & support groups, phone calls/video chats and daily outings with motor and non-motor…CLE-600: Treating nocturnal and early morning OFF symptomology in Parkinson’s disease with the OLAR® platform
Objective: Development of a treatment for nocturnal and early morning OFF symptomology in Parkinson’s disease. Background: Levodopa Parkinson’s disease (PD) treatment is limited by its…Data-driven prediction of fatigue in Parkinson’s disease patients
Objective: The overall aim of this study is to identify which items of the Fatigue Severity Scale (FSS) best predict clinically significant fatigue in male…The Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD): a new tool to assess gastrointestinal dysfunction in Parkinson’s Disease
Objective: Objective: To develop and validate the Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD), a self-report scale designed to assess presence and severity of Gastrointestinal…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 51
- Next Page »